Zoetis to Participate in the Bank of America Merrill Lynch Animal Health Summit
PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb 10, 2020--
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Animal Health Summit on Monday, Feb. 24, 2020, in New York, N.Y. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:40 a.m. ET.
Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion with approximately 10,000 employees. For more information, visit www.zoetis.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200210005108/en/
CONTACT: Media Contacts:
firstname.lastname@example.org Kristen Seely
email@example.com Marissa Patel
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK NEW JERSEY
INDUSTRY KEYWORD: VETERINARY AGRICULTURE BIOTECHNOLOGY NATURAL RESOURCES PHARMACEUTICAL GENERAL HEALTH HEALTH MEDICAL DEVICES
SOURCE: Zoetis Inc.
Copyright Business Wire 2020.
PUB: 02/10/2020 08:30 AM/DISC: 02/10/2020 08:30 AM